Remove market-intelligence organizational-profile
article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

Archana Hegde, Senior Director, Integrated PV Solutions at IQVIA The evolution of artificial intelligence (AI) such as generative AI has just begun. While each company successfully gained FDA approvals, the current market acceptance for prescription digital therapeutics is low and improvements will take years.

Health IT 110
article thumbnail

Planning for the post-COVID-19 workforce: four scenarios

Digital Leaders HealthTech

Substitute a bat in a Wuhan wet market for the butterfly and the spread of the coronavirus for the weather, and you have the same effect showing how fragile and uncertain our world is. Businesses retool their operating models to reach new markets characterized by heightened consumer expectations and global connectivity.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Uses of AI in Healthcare – 2024 Health IT Predictions

Healthcare IT Today

Joel Diamond, MD, Co-Founder/Chief Medical Officer Aranscia; Co-Founder 2bPrecise at Aranscia Artificial intelligence was a major buzzword in the world in 2023, and that was also the case in the healthcare space. We will also see a transition to connected intelligence. 2024 will likely see continued hype regarding A.I.

Health IT 127
article thumbnail

Review of Mobile Devices and Health by Ida Sim in the NEJM

mHealth Insight

“Mobile health is at the swirling confluence of remote sensing, consumer-facing personal technologies, and artificial intelligence (AI). temporal and severity profiles of patient symptoms). Surely Dr Sim is aware of the mess the FDA have made with it’s efforts to regulate the ‘e-cigerette/vaping’ market? .